Thymopentin

胸腺五肽

Report date: 2022/04/26 11:02:11

Base Information

Drug NameThymopentin

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsImmunologic Deficiency SyndromesLupus Erythematosus, SystemicArthritis, Rheumatoid +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsImmunologic Deficiency SyndromesLupus Erythematosus, SystemicArthritis, Rheumatoid +[4]

Inactive IndicationsN/A

ATC CodeL03AX09